Redhill Biopharma
RDHL
44 hedge funds and large institutions have $3.89M invested in Redhill Biopharma in 2022 Q2 according to their latest regulatory filings, with 4 funds opening new positions, 12 increasing their positions, 11 reducing their positions, and 3 closing their positions.
56% more call options, than puts
Call options by funds: $64K | Put options by funds: $41K
33% more first-time investments, than exits
New positions opened: 4 | Existing positions closed: 3
2% more funds holding
Funds holding: 43 → 44 (+1)
9% more repeat investments, than reductions
Existing positions increased: 12 | Existing positions reduced: 11
0% less ownership
Funds ownership: 0% → 0% (-0%)
71% less capital invested
Capital invested by funds: $13.3M → $3.89M (-$9.38M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Millennium Management
New York
|
+$512K |
| 2 |
AIM
ARK Investment Management
St. Petersburg,
Florida
|
+$251K |
| 3 |
Morgan Stanley
New York
|
+$144K |
| 4 |
FDCDDQ
Federation des caisses Desjardins du Quebec
Levis,
Quebec, Canada
|
+$48K |
| 5 |
Group One Trading
Chicago,
Illinois
|
+$43.9K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
DGI
Disciplined Growth Investors
Minneapolis,
Minnesota
|
-$1.56M |
| 2 |
CS
Candriam SCA
Strassen, Luxembourg,
Luxembourg
|
-$180K |
| 3 |
Citadel Advisors
Miami,
Florida
|
-$79.6K |
| 4 |
Cambridge Investment Research Advisors
Fairfield,
Iowa
|
-$65K |
| 5 |
Barclays
London,
United Kingdom
|
-$35.7K |
RDHL Hedge Fund Activity: Q2 2022 in Review
44 of the 5,936 institutional investors tracked by Wall St. Rank reported a position in Redhill Biopharma (RDHL) for Q2 2022, worth a combined $3.89M — down 71% from $13.3M a quarter earlier.
Buyers outnumbered sellers: 4 funds opened new RDHL positions and 3 closed out — a net gain of 1 holder — while 12 added to existing stakes and 11 trimmed.
The largest buyer was Millennium Management, opening a new position worth an estimated $512K. The largest seller was Disciplined Growth Investors, cutting an estimated $1.56M.
- 44 institutional investors held Redhill Biopharma (RDHL) as of Q2 2022, up from 43 in Q1 2022.
- Funds reported $3.89M of Redhill Biopharma stock for Q2 2022, down 71% quarter-over-quarter.
- 4 funds opened new Redhill Biopharma positions in Q2 2022 and 3 closed out, a net change of +1 holder.
- The largest Redhill Biopharma buyer in Q2 2022 was Millennium Management, an estimated $512K added.
- The largest Redhill Biopharma seller in Q2 2022 was Disciplined Growth Investors, an estimated $1.56M sold.
Based on aggregated 13F filings for Q2 2022.